Archives of Plastic Surgery

Korean Society of Plastic and Reconstructive Surgeons (대한성형외과학회)
권호 표지
DOI QR코드

DOI QR Code

Mucormycosis Management in COVID-19 Era: Is Immediate Surgical Debridement and Reconstruction the Answer?

  • Gupta, Samarth (Department of Plastic, Reconstructive and Burns Surgery, Sawai Man Singh Hospital) ;
  • Goil, Pradeep (Department of Plastic, Reconstructive and Burns Surgery, Sawai Man Singh Hospital) ;
  • Mohammad, Arbab (Aarupadai Veedu Medical College and Hospital) ;
  • Escandon, Joseph M. (Division of Plastic and Reconstructive Surgery, Strong Memorial Hospital, University of Rochester Medical Center)
  • Published : 2022.05.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background Excessive use of corticosteroids therapy along with gross immunocompromised conditions in the novel coronavirus disease 2019 (COVID-19) pandemic has raised the risks of contracting opportunistic fungal infections. Here, we describe our experience with the implementation of a surgical protocol to treat and reconstruct rhino-orbital-cerebral mucormycosis. Methods A retrospective review of our prospectively maintained database was conducted on consecutive patients diagnosed with mucormycosis undergoing immediate reconstruction utilizing our "Mucormycosis Management Protocol." All patients included in this study underwent reconstruction after recovering from COVID-19. Wide local excision was performed in all cases removing all suspected and edematous tissue. Reconstruction was done primarily after clear margins were achieved on clinical assessment under a cover of injectable liposomal amphotericin B. Results Fourteen patients were included. The average age was 43.6 years and follow-up was 24.3 days. Thirteen patients had been admitted for inpatient care of COVID-19. Steroid therapy was implemented for 2 weeks in 11 patients and for 3 weeks in 3 patients. Eight patients (57.1%) had a maxillectomy and mucosal lining resection with/without skin excision, and six patients (42.8%) underwent maxillectomy and wide tissue excision (maxillectomy and partial zygomatic resection, orbital exenteration, orbital floor resection, nose debridement, or skull base debridement). Anterolateral thigh (ALT) flaps were used to cover defects in all patients. All flaps survived. No major or minor complications occurred. No recurrence of mucormycosis was noted. Conclusion The approach presented in this study indicates that immediate reconstruction is safe and reliable in cases when appropriate tissue resection is accomplished. Further studies are required to verify the external validity of these findings.

Keywords

References

  1. Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia 2020;185(04):599-606 https://doi.org/10.1007/s11046-020-00462-9
  2. Cornely OA, Arikan-Akdagli S, Dannaoui E, et al; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group European Confederation of Medical Mycology. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 2014;20(Suppl 3):5-26
  3. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis 2012;54(Suppl 1):S16-S22
  4. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 2004;10(Suppl 1):31-47 https://doi.org/10.1111/j.1470-9465.2004.00843.x
  5. Tidwell J, Higuera S, Hollier LH Jr. Facial reconstruction after mucormycosis in an immunocompetent host. Am J Otolaryngol 2005;26(05):333-336 https://doi.org/10.1016/j.amjoto.2005.01.017
  6. Ingram PR, Suthananthan AE, Rajan Ret al.Cutaneous mucormycosis and motor vehicle accidents: findings from an Australian case series. Med Mycol 2014;52(08):819-825 https://doi.org/10.1093/mmy/myu054
  7. Mignogna MD, Fortuna G, Leuci Set al.Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature. Int J Infect Dis 2011;15(08):e533-e540
  8. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 2012;54(Suppl 1):S23-S34 https://doi.org/10.1093/cid/cir866
  9. Kueht M, Villarreal JA, Reece Eet al.Cutaneous mucormycosis in solid organ transplant recipients after Hurricane Harvey: short- and long-term management. Plast Reconstr Surg Glob Open 2019;7(01):e2041 https://doi.org/10.1097/GOX.0000000000002041
  10. Verma DK, Bali RK. COVID-19 and mucormycosis of the craniofacial skeleton: causal, contributory or coincidental? J Maxillofac Oral Surg 2021;20(02):1-2
  11. Roden MM, Zaoutis TE, Buchanan WLet al.Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005;41(05):634-653 https://doi.org/10.1086/432579
  12. Talmi YP, Goldschmied-Reouven A, Bakon Met al.Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol Head Neck Surg 2002;127(01):22-31 https://doi.org/10.1067/mhn.2002.126587
  13. Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021;15(04):102146 https://doi.org/10.1016/j.dsx.2021.05.019
  14. Hosseini SM, Borghei P. Rhinocerebral mucormycosis: pathways of spread. Eur Arch Otorhinolaryngol 2005;262(11):932-938 https://doi.org/10.1007/s00405-005-0919-0
  15. Claustre J, Larcher R, Jouve Tet al.Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy. Ann Intensive Care 2020;10(01):74 https://doi.org/10.1186/s13613-020-00673-9
  16. Kim JG, Park HJ, Park JHet al.Importance of immediate surgical intervention and antifungal treatment for rhinocerebral mucormycosis: a case report. J Korean Assoc Oral Maxillofac Surg 2013;39(05):246-250 https://doi.org/10.5125/jkaoms.2013.39.5.246
  17. Srikanth V, Pradeep KN, Anantheswar YNet al.Cranio-facial mucormycosis-the plastic surgeon's perspective. Eur J Plast Surg 2020;43:239-246 https://doi.org/10.1007/s00238-019-01606-x
  18. Spellberg B, Edwards J Jr., Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005;18(03):556-569 https://doi.org/10.1128/CMR.18.3.556-569.2005
  19. Riley TT, Muzny CA, Swiatlo E, Legendre DP. Breaking the mold: a review of mucormycosis and current pharmacological treatment options. Ann Pharmacother 2016;50(09):747-757 https://doi.org/10.1177/1060028016655425
  20. Oswal NP, Gadre PK, Sathe P, Gadre KS. Mucormycosis of mandible with unfavorable outcome. Case Rep Dent 2012;2012:257940 https://doi.org/10.1155/2012/257940
  21. Silberstein E, Krieger Y, Rosenberg Net al.Facial reconstruction of a mucormycosis survivor by free rectus abdominis muscle flap, tissue expansion, and ocular prosthesis. Ophthal Plast Reconstr Surg 2016;32(06):e131-e132 https://doi.org/10.1097/IOP.0000000000000314
  22. Bhatnagar A, Agarwal A. Naso-orbital fistula and socket reconstruction with radial artery forearm flap following orbital mucormycosis. Natl J Maxillofac Surg 2016;7(02):197-200 https://doi.org/10.4103/0975-5950.201361
  23. Juarez Palacios J, Hanson V, Medina Rendon MA, Lopez-Infante RS. Reconstruction of head and neck mucormycosis: a literature review and own experience in immediate reconstruction. J Reconstr Microsurg Open. 2019;04:e102-e102 https://doi.org/10.1055/s-0040-1701492